Proteomics‐based identification of the role of osteosarcoma amplified‐9 in hepatocellular carcinoma recurrence
Abstract Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies; its recurrence is associated with high mortality and poor recurrence‐free survival and is affected by multisystem and multilevel pathological changes. To identify the key proteins associated with tumor recurrence and...
Main Authors: | Xuyong Wei, Mengfan Yang, Binhua Pan, Xiaobing Zhang, Hanchao Lin, Wangyao Li, Wenzhi Shu, Kun Wang, Abdul Rehman Khan, Xuanyu Zhang, Beini Cen, Xiao Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health/LWW
2022-08-01
|
Series: | Hepatology Communications |
Online Access: | https://doi.org/10.1002/hep4.1952 |
Similar Items
-
Quantitative proteomic profiling of hepatocellular carcinoma at different serum alpha-fetoprotein level
by: Xuyong Wei, et al.
Published: (2022-06-01) -
CLIC1 Drives Angiogenesis in Hepatocellular Carcinoma by Modulating VEGFA
by: Xuyong Wei MD, et al.
Published: (2022-06-01) -
Systemic analysis identifying PVT1/DUSP13 axis for microvascular invasion in hepatocellular carcinoma
by: Renyi Su, et al.
Published: (2023-04-01) -
Cellular crosstalk during liver regeneration: unity in diversity
by: Wenzhi Shu, et al.
Published: (2022-08-01) -
Suppression of osteosarcoma progression by engineered lymphocyte-derived proteomes
by: Kexin Li, et al.
Published: (2023-07-01)